Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new information.
about
Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug CandidateComparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients.Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system.Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines.RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches.Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination.Tolerability of Antihypertensive Medications in Older Adults.Phase 4 Studies in Heart Failure - What is Done and What is Needed?Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population.ACE inhibitors versus ARBs versus DRIs: a systematic update.Newer is not always better: all antihypertensive medications do not equally reduce cardiovascular risk.Patterns and predictors of physician adoption of new cardiovascular drugs.Early health technology assessments in pharmacogenomics: a case example in cardiovascular drugs.The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case/noncase study in VigiBase.Treatment of angiotensin receptor blocker-induced angioedema: A case series.
P2860
Q26782938-2E74FFB5-7CFF-4CD2-9EB2-FB21F72504D5Q33730477-B5796A24-681E-4BCE-997C-FB662B491232Q34232188-0FFDABF8-A6D7-49D8-A8F5-63E868CC1852Q36137337-93AB7B99-8B68-4E34-BB01-9C7858E87BE6Q36551388-19B61060-BEE5-4B1E-AA8C-38B1B4A777D8Q36975796-3142E945-FAEC-421D-8B0F-F11196885055Q38600758-AB3507A4-E73A-47E2-AAD3-D8849C417073Q38859866-B71A45F8-0CAB-43F3-B33F-62EECD563188Q40382144-FFE5DC47-8FCA-4926-8CB3-33ACC83A0B24Q42364889-3B7B1248-D457-44D3-865F-BA071CFEB0F6Q43180778-F8090C0B-AD87-478D-8999-63BBA850383DQ46590970-48FBAF36-9B73-44B6-90FF-0DD925547EC9Q47821070-5BF8A6CA-4C61-4B0C-9625-6305BA36D12FQ48306249-03767B93-E467-4080-AEF6-DF437DFB251AQ53621000-D16EB7CC-32C3-409F-B866-A0EACD7F37E6
P2860
Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new information.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Updated report on comparative ...... data, little new information.
@ast
Updated report on comparative ...... data, little new information.
@en
Updated report on comparative ...... data, little new information.
@nl
type
label
Updated report on comparative ...... data, little new information.
@ast
Updated report on comparative ...... data, little new information.
@en
Updated report on comparative ...... data, little new information.
@nl
prefLabel
Updated report on comparative ...... data, little new information.
@ast
Updated report on comparative ...... data, little new information.
@en
Updated report on comparative ...... data, little new information.
@nl
P2093
P2860
P1476
Updated report on comparative ...... data, little new information.
@en
P2093
Amy S Kendrick
Benjamin J Powers
Gillian D Sanders
R Julian Irvine
Rebecca N Gray
Remy R Coeytaux
Rowena J Dolor
Uptal D Patel
William S Yancy
P2860
P2888
P304
P356
10.1007/S11606-011-1938-8
P577
2011-12-07T00:00:00Z
P5875
P6179
1012128233